ERYTHROMYCIN AND BENZOYL PEROXIDE
Clinical safety rating: safe
Inhibits CYP3A4 increasing levels of many drugs (eg statins carbamazepine) May cause QT prolongation and subsequent arrhythmias.
Erythromycin is a macrolide antibiotic that acts by binding to the 50S ribosomal subunit of susceptible bacteria, inhibiting protein synthesis. Benzoyl peroxide has bactericidal effects against Propionibacterium acnes, likely through the release of free radical oxygen that oxidizes bacterial proteins. It also has keratolytic and comedolytic properties.
| Metabolism | Erythromycin is partially metabolized via demethylation in the liver, primarily by CYP3A4. Benzoyl peroxide is metabolized in the skin to benzoic acid, which is then excreted renally. |
| Excretion | Erythromycin is primarily excreted via bile (fecal elimination) with approximately 15% excreted unchanged in urine. Benzoyl peroxide is degraded to benzoic acid, which is conjugated with glycine to form hippuric acid and excreted renally; less than 5% is excreted unchanged in urine. |
| Half-life | Erythromycin: 1.4–2.0 hours (terminal half-life in adults). Benzoyl peroxide: Not applicable; it is a topical agent with negligible systemic absorption. |
| Protein binding | Erythromycin: 70–90% bound, primarily to albumin. Benzoyl peroxide: Not applicable; topical absorption is minimal (<5%). |
| Volume of Distribution | Erythromycin: Vd = 0.4–0.6 L/kg, indicating distribution into total body water. Benzoyl peroxide: Not applicable due to minimal systemic absorption. |
| Bioavailability | Erythromycin base: 35–45% (oral). Benzoyl peroxide: <5% systemically absorbed after topical application. |
| Onset of Action | Topical: Clinical improvement in acne vulgaris typically seen within 2–4 weeks of regular application. |
| Duration of Action | Topical: Effect lasts 8–12 hours; requires twice-daily application for sustained efficacy. |
| Molecular Weight | Erythromycin: 733.93 Da. Benzoyl peroxide: 242.23 Da. |
Topical: Apply a thin layer to affected areas once daily in the evening.
| Dosage form | GEL |
| Renal impairment | No adjustment required for topical use; systemic absorption is negligible. |
| Liver impairment | No adjustment required for topical use; systemic absorption is negligible. |
| Pediatric use | Approved for adolescents ≥12 years: same as adult dose. For children <12 years, safety and efficacy not established. |
| Geriatric use | No specific dose adjustment; use with caution due to potential for increased skin sensitivity or dryness. |
| 1st trimester | Erythromycin is considered safe in pregnancy (category B). Benzoyl peroxide has low systemic absorption and is generally considered safe topically. Avoid large areas or high concentrations. |
| 2nd trimester | Same as T1. Erythromycin is compatible. |
| 3rd trimester | Same as T1. Erythromycin is compatible, but use near term with caution due to potential risk of infantile hypertrophic pyloric stenosis. |
Clinical note
Inhibits CYP3A4 increasing levels of many drugs (eg statins carbamazepine) May cause QT prolongation and subsequent arrhythmias.
| FDA category | Human |
| Placental transfer | Erythromycin crosses the placenta with measurable fetal serum levels approximately 5-20% of maternal levels. Benzoyl peroxide is not systemically absorbed, minimal to no placental transfer. |
■ FDA Black Box Warning
None
| Common Effects | Nausea |
| Serious Effects |
Hypersensitivity to erythromycin, benzoyl peroxide, or any component of the formulationConcomitant use of erythromycin with certain drugs that prolong QT interval (e.g., cisapride, pimozide) due to risk of cardiac arrhythmias
| Precautions | Avoid contact with eyes, mouth, and mucous membranes, May cause skin irritation, dryness, or peeling, Photosensitivity may occur with benzoyl peroxide, Antibiotic resistance with prolonged use, May stain clothing or hair |
| Food/Dietary | No clinically significant food interactions reported. Erythromycin systemic absorption is minimal with topical use; benzoyl peroxide has no known food interactions. |
Loading safety data…
| Breastfeeding |
| Erythromycin is excreted into breast milk in small amounts and is considered compatible. Benzoyl peroxide has minimal systemic absorption. Guidance: topical application to small areas is unlikely to pose risk. Avoid application to breast or nipple area. |
| Lactation Rating | L2 (Safer) - compatible with breastfeeding. |
| Teratogenic Risk | No evidence of teratogenicity in animal studies for erythromycin. For benzoyl peroxide, limited data but no known teratogenicity. Insufficient human data for combination. Risk cannot be excluded; use only if clearly needed. |
| Fetal Monitoring | No specific monitoring required beyond standard prenatal care. Observe for maternal skin irritation or allergic reaction; fetal effects not established. |
| Fertility Effects | No known effect on fertility from erythromycin or benzoyl peroxide. No human studies on combination. |
| Clinical Pearls | Apply sparingly to acne-prone areas only; avoid contact with eyes, mouth, and mucous membranes. Use with caution in patients with eczema or sensitive skin due to potential irritation. Combination enhances antibacterial efficacy and reduces antibiotic resistance risk. Store at room temperature; discard after expiration due to benzoyl peroxide degradation. Advise sun protection as benzoyl peroxide increases photosensitivity. |
| Patient Advice | Apply a thin layer to affected areas once or twice daily as directed. · Wash hands before and after application; avoid contact with eyes, lips, and nose. · May cause dryness, peeling, or redness; use a non-comedogenic moisturizer if needed. · Expect initial worsening of acne; improvement may take 4-6 weeks. · Use sunscreen daily and avoid excessive sun exposure due to photosensitivity. · Do not use more than prescribed; avoid mixing with other topical acne products without consulting doctor. · Store at room temperature; do not freeze. Keep away from heat and open flame (flammable). · If skin becomes severely irritated or allergic reaction occurs (hives, swelling), discontinue use and seek medical help. |